PreveCeutical Medical Inc. (PREV.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -296.97 Thousand | -222.64 Thousand | -426.39 Thousand | 64.59 Thousand | -993.93 Thousand | -7.57 Million |
| Net Income | -1.27 Million | -1.48 Million | -1.72 Million | -3.8 Million | -3.57 Million | -11.88 Million |
| Depreciation & Amortization | 9856.00 | 9891.00 | 5092.00 | 75.16 Thousand | 174.53 Thousand | 36.28 Thousand |
| Deferred income taxes | - | -22.46 Thousand | -20.47 Thousand | -6150.00 | -7875.00 | -40.34 Thousand |
| Stock-based compensation | 131.44 Thousand | 334.1 Thousand | 90.06 Thousand | 1.16 Million | 433.44 Thousand | 1.1 Million |
| Change in working capital | 527.2 Thousand | 494.89 Thousand | 592.84 Thousand | 698.29 Thousand | 1.4 Million | -1.87 Million |
| Other non-cash items | 447.03 Thousand | 442.3 Thousand | 632.65 Thousand | 1.93 Million | 578.68 Thousand | 5.08 Million |
| Investing Cash Flow | - | 850.00 | -52.69 Thousand | -2651.00 | -1330.00 | -10.58 Thousand |
| Investments in PPE | 4.00 | - | -55.19 Thousand | -2651.00 | -1330.00 | -10.58 Thousand |
| Acquisitions | - | 850.00 | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 0.85 | 2500.00 | -2.65 | -1.33 | -2912.00 |
| Financing Cash Flow | 293.62 Thousand | 211.71 Thousand | 136.75 Thousand | 184.46 Thousand | 867.02 Thousand | 7.54 Million |
| Debt repayment | -293.62 Thousand | -218.2 Thousand | -136.75 Thousand | -45.48 Thousand | -215.93 Thousand | -683.93 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -6489.00 | - | 2500.00 | 279.3 Thousand | 6.26 Million |
| Other Financing Activities | 293.62 Thousand | -6489.00 | 273.5 Thousand | 227.45 Thousand | 803.65 Thousand | 1.96 Million |
| Accounts receivables | 13.11 Thousand | -2353.00 | 35.72 Thousand | 6086.00 | -20.35 Thousand | -204.00 |
| Accounts payables | - | - | - | 487.18 Thousand | 71.56 Thousand | 338.98 Thousand |
| Inventory | - | - | - | -487.18 Thousand | - | 4203.00 |
| Other working capital | 514.09 Thousand | 497.24 Thousand | 557.12 Thousand | 692.21 Thousand | 1.35 Million | -2.21 Million |
| Cash at beginning of period | 5624.00 | 16.06 Thousand | 156.44 Thousand | 28.48 Thousand | 64.32 Thousand | 104.47 Thousand |
| Cash at end of period | 1432.00 | 5624.00 | 16.06 Thousand | 156.44 Thousand | 28.48 Thousand | 64.32 Thousand |
| Capital Expenditure | 4.00 | - | -55.19 Thousand | -2651.00 | -1330.00 | -10.58 Thousand |
| Effect of forex changes on cash | -842.00 | -363.00 | 201.96 Thousand | -118.44 Thousand | 92.39 Thousand | -1664.00 |
| Net cash flow / Change in cash | -4192.00 | -10.43 Thousand | -140.37 Thousand | 127.96 Thousand | -35.84 Thousand | -40.14 Thousand |
| Free Cash Flow | -296.97 Thousand | -222.64 Thousand | -481.58 Thousand | 61.94 Thousand | -995.26 Thousand | -7.58 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -361.96 Thousand | -235.4 Thousand | -423.06 Thousand | -1.27 Million | -239.63 Thousand | -230.57 Thousand |
| Depreciation & Amortization | 2522.00 | 2499.00 | 2450.00 | 9856.00 | 2436.00 | 2481.00 |
| Deferred income taxes | - | - | - | - | -3705.83 | -4439.96 |
| Stock-based compensation | - | - | 42.29 Thousand | 131.44 Thousand | 2826.00 | 8957.00 |
| Change in working capital | 89.62 Thousand | 95.42 Thousand | 261.8 Thousand | 527.2 Thousand | 106.57 Thousand | 26.73 Thousand |
| Other non-cash items | 93.65 Thousand | 84.29 Thousand | 128.83 Thousand | 447.03 Thousand | 85.86 Thousand | 89.92 Thousand |
| Investing Cash Flow | -170.00 | -779.00 | - | - | -120.88 | 3282.00 |
| Investments in PPE | -170.00 | -779.00 | - | - | - | 3282.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 3282.00 |
| Financing Cash Flow | 189.78 Thousand | 60.44 Thousand | 37.19 Thousand | 293.62 Thousand | 48.58 Thousand | 107.99 Thousand |
| Debt repayment | -83.98 Thousand | -60.44 Thousand | -37.19 Thousand | -293.62 Thousand | -48.58 Thousand | -107.99 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 105.8 Thousand | - | - | - | - | - |
| Other Financing Activities | 189.78 Thousand | 60.44 Thousand | 37.19 Thousand | 293.62 Thousand | 48.58 Thousand | 107.99 Thousand |
| Accounts receivables | -9391.00 | -232.00 | -2297.00 | 13.11 Thousand | 1169.00 | 531.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 99.01 Thousand | 95.65 Thousand | 264.1 Thousand | 514.09 Thousand | 105.4 Thousand | 26.2 Thousand |
| Cash at beginning of period | 2811.00 | 1432.00 | 1683.00 | 5624.00 | 2511.00 | 6079.00 |
| Cash at end of period | 234.00 | 2811.00 | 1432.00 | 1432.00 | 1683.00 | 2511.00 |
| Capital Expenditure | -170.00 | -779.00 | - | - | - | 3282.00 |
| Effect of forex changes on cash | -1599.00 | 135.00 | -269.00 | -842.00 | -949.00 | 1029.00 |
| Net cash flow / Change in cash | -2577.00 | 1379.00 | -251.00 | -4192.00 | -828.00 | -3568.00 |
| Free Cash Flow | -190.76 Thousand | -59.19 Thousand | -37.17 Thousand | -296.97 Thousand | -48.46 Thousand | -112.58 Thousand |
RECY-B
7561
GGGSY
XBIT
89988
KONMY